Keybanc analyst John Vinh maintains Monolithic Power Systems (NASDAQ:MPWR) with a Overweight and lowers the price target from $580 to $500.
What’s Going On With Biodexa Pharmaceuticals Stock?
Biodexa Pharmaceuticals (NASDAQ:BDRX) stock is trading higher. The company on Tuesday announced progress towards the treatment of Familial Adenomatous Polyposis.